Gaining Ground: Emerson Electric Co. (EMR) Closes Lower at 106.87, Down -1.98

In the pursuit of market outperformance, investors navigate the landscape of stock selection. The right picks can play a pivotal role in enhancing your wealth.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free

The price of Emerson Electric Co. (NYSE: EMR) closed at $106.87 in the last session, down -1.98% from day before closing price of $109.03. In other words, the price has decreased by -$1.98 from its previous closing price. On the day, 3.0 million shares were traded. EMR stock price reached its highest trading level at $108.88 during the session, while it also had its lowest trading level at $106.51.


We take a closer look at EMR’s different ratios to gain a better understanding of the stock. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 26.38 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 67.34. For the most recent quarter (mrq), Quick Ratio is recorded 0.87 and its Current Ratio is at 1.18. In the meantime, Its Debt-to-Equity ratio is 0.55 whereas as Long-Term Debt/Eq ratio is at 0.39.

Upgrades & Downgrades

In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Deutsche Bank on May 09, 2024, Upgraded its rating to Buy and sets its target price to $138 from $123 previously.

On January 04, 2024, Mizuho Upgraded its rating to Buy which previously was Neutral and also upped its target price recommendation from $95 to $118.

On October 03, 2023, KeyBanc Capital Markets started tracking the stock assigning a Overweight rating and target price of $120.KeyBanc Capital Markets initiated its Overweight rating on October 03, 2023, with a $120 target price.

Insider Transactions:

An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Mar 04 ’24 when Piazza Nicholas J. sold 2,200 shares for $108.50 per share. The transaction valued at 238,700 led to the insider holds 22,754 shares of the business.

LEVATICH MATTHEW S sold 1,933 shares of EMR for $204,081 on Feb 15 ’24. The Director now owns 24,965 shares after completing the transaction at $105.58 per share. On Feb 14 ’24, another insider, Karsanbhai Surendralal Lanca, who serves as the President & CEO of the company, sold 2,344 shares for $106.02 each. As a result, the insider received 248,513 and left with 138,750 shares of the company.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, EMR now has a Market Capitalization of 61140324352 and an Enterprise Value of 76127641600. As of this moment, Emerson’s Price-to-Earnings (P/E) ratio for their current fiscal year is 504.58, and their Forward P/E ratio for the next fiscal year is 17.76. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 37.45. For the stock, the TTM Price-to-Sale (P/S) ratio is 3.70 while its Price-to-Book (P/B) ratio in mrq is 2.93. Its current Enterprise Value per Revenue stands at 4.606 whereas that against EBITDA is 16.343.

Stock Price History:

Over the past 52 weeks, EMR has reached a high of $116.76, while it has fallen to a 52-week low of $81.81. The 50-Day Moving Average of the stock is -4.34%, while the 200-Day Moving Average is calculated to be 6.41%.

Shares Statistics:

According to the various share statistics, EMR traded on average about 2.59M shares per day over the past 3-months and 2461770 shares per day over the past 10 days. A total of 572.00M shares are outstanding, with a floating share count of 569.85M. Insiders hold about 0.39% of the company’s shares, while institutions hold 77.05% stake in the company. Shares short for EMR as of 1715731200 were 5352070 with a Short Ratio of 2.06, compared to 1713139200 on 6411119. Therefore, it implies a Short% of Shares Outstanding of 5352070 and a Short% of Float of 0.9400000000000001.

Dividends & Splits

The forward annual dividend rate for EMR is 2.10, which was 2.09 in the trailing 12 months. Against a Trailing Annual Dividend Yield of 0.019169036The stock’s 5-year Average Dividend Yield is 2.49.

Most Popular